Peptide receptor radionuclide therapy (PRRT) is a successful targeted radionuclide therapy
in neuroendocrine tumors (NETs). However, complete responses remain elusive. Combined …

Diagnosis of neuroendocrine tumors (NETs) has increased significantly over the past
decade. Successful detection of metastatic diseases has been achieved through …

Simple Summary Well-structured international guidelines are currently available regarding
the management of patients with neuroendocrine neoplasms (NENs). However, in relation to …

Important progress has been made over the last decade in the classification, imaging, and
treatment of neuroendocrine neoplasm (NENs), with several new agents approved for use …

Purpose To provide guidance, via multidisciplinary consensus statements, on the safety
interactions between systemic anticancer agents (such as radiosensitizing chemotherapy …

This study reports the development and evaluation of yttrium-90 (90Y) radiolabeled silica-
coated iron oxide (SiO 2-Fe 3 O 4) resin microspheres for potential theranostic application in …

Purpose: The aim of this study was to evaluate the effect of an increase in the time interval
between hepatic intra-arterial injection of 99mTc-macroaggregated albumin (MAA) and …

Accurate dosimetric calculations are essential to enhance therapeutic efficacy in Yttrium-90
(Y-90) microsphere therapy, which rely significantly on the three-dimensional imaging …

Background: Insulin-secreting tumors are the most common hormone-producing neoplasm
of the gastrointestinal tract. Only 10 percent of overall cases of insulinoma have malignant …

Nükleer tıbbın gelişimi ile uygulanan tedaviler ve tedavilerin etkinliği gün geçtikçe artarak
devam etmektedir. Yaygın olarak uygulanan sistemik tedavilerde amaç, damar içine verilen …